环境性肠功能障碍与全球儿童生长失败/发育迟缓
全球约25%的5岁以下儿童存在生长迟缓,与死亡率增加、认知功能障碍和生产力损失相关,2030年全球目标是将生长迟缓儿童数量减少40%。生长迟缓的发病机制尚不清楚,但产前和产后营养缺乏及肠道和全身感染明确 contribut,近期研究提示环境性肠功能障碍(EED)起核心作用。EED 是不卫生条件下儿童高发的小肠结构和功能弥漫性紊乱,其导致生长失败的机制包括肠道渗漏和通透性增高、肠道炎症、菌群失调和细菌易位、全身炎症及营养吸收不良。由于 EED 有多条因果通路,管理需多方面的干预。
要点
- EED 是不卫生条件下儿童高发的小肠结构和功能弥漫性紊乱,与生长迟缓密切相关。
- EED 导致生长失败的机制包括肠道渗漏、炎症、菌群失调、细菌易位和营养吸收不良。
- EED 管理需多方面干预,包括改善卫生、母乳喂养、益生菌、营养补充、抗炎和抗生素等。
核心结论
- EED 在不卫生条件下儿童中高发,是生长迟缓的重要贡献因素,其管理需多方面的干预。
- 更好地理解 EED 的潜在原因并开发非侵入、实用、简单且负担得起的即时诊断工具仍是关键空白。
研究设计与样本
- 本文为综述,未报告系统检索范围。
主要发现
- 全球约25%的5岁以下儿童存在生长迟缓,与死亡率增加、认知功能障碍和生产力损失相关。
- EED 导致生长失败的机制包括肠道渗漏和通透性增高、肠道炎症、菌群失调和细菌易位、全身炎症及营养吸收不良。
关键数值与推荐
- 2030年全球目标是将生长迟缓儿童数量减少40%。
- 潜在干预措施包括:通过改善水、环境卫生和个人卫生等项目减少粪便暴露和动物接触;母乳喂养和增强饮食多样性;益生菌和益生元;营养补充剂,包括锌、多不饱和脂肪酸和氨基酸;抗炎药物如5-氨基水杨酸;以及在急性营养不良和感染背景下使用抗生素。
临床怎么用
- 对生长迟缓儿童应考虑 EED 的可能,并评估其肠道炎症、通透性及营养吸收状况。
- 管理 EED 需采取多方面干预,包括改善卫生条件、母乳喂养、营养补充、益生菌及抗炎或抗生素治疗。
局限性
- EED 的发病机制尚不清楚。
- 需要更好地理解 EED 的潜在原因,并开发非侵入、实用、简单且负担得起的即时诊断工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Approximately 25% of the world's children aged <5 years have stunted growth, which is associated with increased mortality, cognitive dysfunction, and loss of productivity. Reducing by 40% the number of stunted children is a global target for 2030. The pathogenesis of stunting is poorly understood. Prenatal and postnatal nutritional deficits and enteric and systemic infections clearly contribute, but recent findings implicate a central role for environmental enteric dysfunction (EED), a generalized disturbance of small intestinal structure and function found at a high prevalence in children living under unsanitary conditions. Mechanisms contributing to growth failure in EED include intestinal leakiness and heightened permeability, gut inflammation, dysbiosis and bacterial translocation, systemic inflammation, and nutrient malabsorption. Because EED has multiple causal pathways, approaches to manage it need to be multifaceted. Potential interventions to tackle EED include: (1) reduction of exposure to feces and contact with animals through programs such as improved water, sanitation, and hygiene; (2) breastfeeding and enhanced dietary diversity; (3) probiotics and prebiotics; (4) nutrient supplements, including zinc, polyunsaturated fatty acids, and amino acids; (5) antiinflammatory agents such as 5-aminosalicyclic acid; and (6) antibiotics in the context of acute malnutrition and infection. Better understanding of the underlying causes of EED and development of noninvasive, practical, simple, and affordable point-of-care diagnostic tools remain key gaps. "Omics" technologies (genomics, epigenomics, transcriptomics, proteomics, and metabolomics) and stable isotope techniques (eg, 13C breath tests) targeted at children and their intestinal microbiota will enhance our ability to successfully identify, manage, and prevent this disorder.
引用
- Owino V, Ahmed T, Freemark M, et al. Environmental Enteric Dysfunction and Growth Failure/Stunting in Global Child Health. Pediatrics. 2016. PMID: 27940670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。